Literature DB >> 2917993

Purification and properties of a soluble angiotensin II-binding protein from rabbit liver.

M A Kiron1, R L Soffer.   

Abstract

An angiotensin II-binding activity has been purified almost 3,000-fold to a nearly homogenous state from the 100,000 x g supernatant fraction of rabbit liver. The responsible protein is apparently monomeric since its molecular weight was estimated to be 75,000 in the native state by glycerol gradient centrifugation and in the reduced, denatured state by gel electrophoresis. The Kd and Bmax values of the purified preparation were 7.2 nM and 15.2 nmol of angiotensin II bound per mg of protein, the latter figure agreeing well with the theoretical value of 13.3. Competition experiments with 125I-angiotensin II and unlabeled peptides revealed that the angiotensin antagonist [Sar1,Ala8]angiotensin II (saralasin) and the agonist [des-Asp1]angiotensin II (angiotensin III) were more tightly bound than angiotensin II, whereas angiotensin I and the carboxyl-terminal hexapeptide were less avidly bound. The cardiac peptide, atrial natriuretic factor, also competed for binding to the purified preparation but was about 15-fold less effective than angiotensin II. Although the binding activity was purified in the absence of detergent, a requirement for detergent in the binding reaction emerged during the isolation procedure. Binding by the purified protein exhibited an almost complete dependence upon the presence of detergent, p-chloromercuriphenylsulfonic acid and EDTA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2917993

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Human brain contains a novel non-AT1, non-AT2 binding site for active angiotensin peptides.

Authors:  Vardan T Karamyan; Craig A Stockmeier; Robert C Speth
Journal:  Life Sci       Date:  2008-07-22       Impact factor: 5.037

2.  Contractile effects by intracellular angiotensin II via receptors with a distinct pharmacological profile in rat aorta.

Authors:  E Brailoiu; C M Filipeanu; A Tica; C P Toma; D de Zeeuw; S A Nelemans
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

3.  Identification of membrane-bound variant of metalloendopeptidase neurolysin (EC 3.4.24.16) as the non-angiotensin type 1 (non-AT1), non-AT2 angiotensin binding site.

Authors:  Naomi J Wangler; Kira L Santos; Ines Schadock; Fred K Hagen; Emanuel Escher; Michael Bader; Robert C Speth; Vardan T Karamyan
Journal:  J Biol Chem       Date:  2011-10-28       Impact factor: 5.157

4.  Thimet oligopeptidase: similarity to 'soluble angiotensin II-binding protein' and some corrections to the published amino acid sequence of the rat testis enzyme.

Authors:  N McKie; P M Dando; N D Rawlings; A J Barrett
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

Review 5.  Brain angiotensin receptors and binding proteins.

Authors:  Robert C Speth; Vardan T Karamyan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-01-03       Impact factor: 3.000

6.  Purification and characterization of angiotensin II AT2 receptors from neonatal rat kidney.

Authors:  G M Ciuffo; F M Heemskerk; J M Saavedra
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.